Across TCGA pan-cancer cohorts, EXOC3L4 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated EXOC3L4 data layer compared with 26 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher EXOC3L4 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated EXOC3L4 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

LUAD and CCRCC are the cancer types where EXOC3L4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	0.279	1.000	<.001	22	view →
CCRCC	OS	Tertile	III,IV	0.858	0.513	.030	10	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: EXOC3L4 tumor-vs-normal RNA expression · all EXOC3L4 data types